THE ROLE OF IL-23 IN PSORIASIS AND PSORIATIC ARTHRITIS: WHAT’S NEW?
Join the Skin Health Institute in this exploration of the role Interleukin 23 (IL-23) plays in the inflammatory pathology observed in psoriasis and psoriatic arthritis (PsA). A/Prof Peter Foley will be presenting on the following topics:
- Understanding the IL-23 pathway in driving psoriasis
- Understanding the pathophysiology for PsA
- What’s new in the management of PsA?
A/PROF PETER FOLEY
Associate Professor Peter Foley is a clinical dermatologist and has a wealth of experience in dermatology particularly in the treatment of psoriasis. He is Australia’s only councillor on the International Psoriasis Council and served on the steering committee of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis).
A/Prof Foley currently holds the positions of Associate Professor, Department of Medicine (Dermatology) at The University of Melbourne, Director of Research at the Skin Health Institute and Head, Dermatology Research, St Vincent's Hospital Melbourne. He is a visiting dermatologist at the Photobiology, Phototherapy and Biologics Clinics at St. Vincent's Hospital Melbourne, and the Phototherapy and Biologics Clinics at the Skin Health Institute.
As the Director of Research, A/Prof Foley directs the Institute's rapidly expanding clinical trials program and is co-convenor of the Australasian Psoriasis Registry. To date he has been an author on well over 100 peer-reviewed publications, including the reports of many of the pivotal trials of biologics in psoriasis and has been an investigator in over 100 clinical trials, many for new therapies for psoriasis.